Showing 2011-2020 of 10225 results for "".
Dermatology Q&A: Treating Melasma and Photoaging Without Hydroquinone
https://practicaldermatology.com/topics/general-topics/dermatology-qa-treating-melasma-and-photoaging-without-hydroquinone/21867/A recently unveiled skin brightening cream may signal a new direction in the treatment and prevention of pigmentation disorders.Take 5: Clinically-Relevant Findings About Causes and Treatment of Rosacea
https://practicaldermatology.com/columns/take-5/take-5-clinically-relevant-findings-about-causes-and-treatment-of-rosacea/21870/Research sheds light on the pathogenesis of the disease and patients' experience.Business Advisor: Before/After Pictures Are Worth More Than Words to Aesthetic Practices
https://practicaldermatology.com/topics/general-topics/business-advisor-beforeafter-pictures-are-worth-more-than-words-to-aesthetic-practices/21887/High-quality before and after pictures are a necessity in today's competitive marketplace. Make an investment in equipment and in training yourself and your staff.Take 5: Promising Developments in Vitiligo Research
https://practicaldermatology.com/columns/take-5/promising-developments-in-vitiligo-research/21924/New studies suggest therapeutic pearls for the management of vitiligo and highlight new approaches to understanding the disorder.Is Bone Mineral Density Testing Indicated with Long-Term IM Triamcinolone Acetonide Therapy?
https://practicaldermatology.com/topics/general-topics/PD1208_05-php/22603/Prospective data are lacking, but early findings suggest little if any risk of density-loss among patients on long-term therapy.Who Is the Man at the Back?
https://practicaldermatology.com/issues/novemberdecember-2025/who-is-the-man-at-the-back/48887/The addiction to applause can often cloud the view of our surroundings and disconnect us from those who are not our allies.GLP-1RAs and the Dermatologist
https://practicaldermatology.com/issues/novemberdecember-2025/glp-1ras-and-the-dermatologist/48885/We are only beginning to understand the implications of GLP-1s for skin and systemic health. These medications are here to stay, and dermatology must be part of the conversation.A Guide to Building Lifelong Patient Loyalty
https://practicaldermatology.com/issues/october-2025/a-guide-to-building-lifelong-patient-loyalty/39758/Interest in medical aesthetic treatments continues to grow and signs indicate that demand will remain strong. Today’s patients are more informed and educated than ever and are seeking personalized, high-quality experiences.What (More) Do You Want From Me? Reflections on Mentorship, Dermatology, and Moving Forward
https://practicaldermatology.com/issues/september-2025/what-more-do-you-want-from-me-reflections-on-mentorship-dermatology-and-moving-forward/37625/Professionally and personally, it’s hard to avoid the “what if” and “if only” scenarios. But when those thoughts outweigh the pride in where we’ve landed or who we’ve become, maybe it’s time to pause and appreciate the labor and sacrifices that got us here.Mergers and Acquisitions in Derm and Aesthetics: Market Outlook
https://practicaldermatology.com/issues/september-2025/mergers-and-acquisitions-in-derm-and-aesthetics-market-outlook/37631/We took a deeper look into the dermatology and aesthetics mergers and acquisitions (M&A) market in a conversation with two of our team members, Drew Thomas and Jordan Frickle, who are closely involved in this sector. The following discussion brings together their perspectives on current trends,